• 1
    Harrigan SM, Mcgorry PD, Krstev H. Does treatment delay in first-episode psychosis really matter? Psychol Med 2003;33:97110.
  • 2
    Larsen TK, Friis S, Haahr U et al. Early detection and intervention in first-episode schizophrenia: a critical review. Acta Psychiatr Scand 2001;103:323334.
  • 3
    Mcgorry PD. Early psychosis reform: too fast or too slow? Acta Psychiatr Scand 2002;106:249251.
  • 4
    Norman RM, Malla AK. Duration of untreated psychosis: a critical examination of the concept and its importance. Psychol Med 2001;31:381400.
  • 5
    Pelosi AJ, Birchwood M. Is early intervention for psychosis a waste of valuable resources? Br J Psychiatry 2003;182:196198.
  • 6
    Riecher-Rössler A, Gschwandtner U, Borgwardt S, Aston J, Pflüger M, Rössler W. Early detection and treatment of schizophrenia: how early? Acta Psychiatr Scand Suppl 2006;113:7380.
  • 7
    Drake RJ, Lewis SW. Early detection of schizophrenia. Curr Opin Psychiatry 2005;18:147150.
  • 8
    Drake RJ, Haley CJ, Akhtar S, Lewis SW. Causes and consequences of duration of untreated psychosis in schizophrenia. Br J Psychiatry 2000;177:511515.
  • 9
    Johnstone EC, Ebmeier KP, Miller P, Owens DG, Lawrie SM. Predicting schizophrenia: findings from the Edinburgh High-Risk Study. Br J Psychiatry 2005;186:1825.
  • 10
    Klosterkötter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001;58:158164.
  • 11
    Mcgorry PD, Yung AR, Phillips LJ. ‘‘Closing in’’ what features predict the onset of first-episode psychosis within an ultra-high-risk group? In ZipurskyRB, SchulzSC, eds. The Early Stages of Schizophrenia. Washington DC, London: American Psychiatric Publishing Inc., 2002: 331.
  • 12
    Yung AR, Phillips LJ, Yuen HP, Mcgorry PD. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res 2004;67:131142.
  • 13
    Olsen KA, Rosenbaum B. Prospective investigations of the prodromal state of schizophrenia: review of studies. Acta Psychiatr Scand 2006;113:247272.
  • 14
    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-III-R, 3rd edn – revised. Washington DC: American Psychiatric Association, 1987.
  • 15
    Lukoff D, Nuechterlein KH, Ventura J. Manual for the expanded brief psychiatric rating scale. Schizophr Bull 1986;12:594602.
  • 16
    Ventura J, Lukoff D, Nuechterlein KH, Liberman RP, Green M, Shaner A. Training and quality assurance with the brief psychiatric rating scale: ‘‘The Drift Busters’’; Appendix 1 The Brief Psychiatric Rating Scale (expanded version). Int J Meth Psychiatric Res 1993;3:221224.
  • 17
    Yung AR, Phillips LJ, Mcgorry PD et al. Prediction of psychosis. A step towards indicated prevention of schizophrenia. Br J Psychiatry Suppl 1998;172:1420.
  • 18
    Heinimaa M, Salokangas RK, Ristkari T et al. PROD-screen – a screen for prodromal symptoms of psychosis. Int J Meth Psychiatr Res 2003;12:92104.
  • 19
    Loewy RL, Bearden CE, Johnson JK, Raine A, Cannon TD. The prodromal questionnaire (PQ): preliminary validation of a self-report screening measure for prodromal and psychotic syndromes. Schizophr Res 2005;77:141149.
  • 20
    Ord LM, Myles-Worsley M, Blailes F, Ngiralmau H. Screening for prodromal adolescents in an isolated high-risk population. Schizophr Res 2004;71:507508.
  • 21
    Miller TJ, Cicchetti D, Markovich PJ, Mcglashan TH, Woods SW. The SIPS screen: a brief self-report screen to detect the schizophrenia prodrome. Schizophr Res 2004;70(Suppl.):78.
  • 22
    Olsen KA, Rosenbaum B. Prospective investigations of the prodromal state of schizophrenia: assessment instruments. Acta Psychiatr Scand 2006;113:273282.
  • 23
    Andreasen NC. The scale for the assessment of negative symptoms (SANS): Conceptual and theoretic foundations. Br J Psychiatry 1989;155:4952.
  • 24
    Fisher LD, Van belle G. Biostatistics – a methodology for the health sciences. New York: John Wiley & Sons, Inc., 1993.
  • 25
    Malla AK, Norman RM. Early intervention in schizophrenia and related disorders: advantages and pitfalls. Curr Opin Psychiatry 2002;15:1723.
  • 26
    Mcgorry PD. The recognition and optimal management of early psychosis. An evidence-based reform. World Psychiatry 2002;1:7683.
  • 27
    Verdoux H, Cougnard A. The early detection and treatment controversy in schizophrenia research. Curr Opin Psychiatry 2003;16:175179.
  • 28
    Häfner H, Maurer K, Löffler W et al. The ABC Schizophrenia Study: a preliminary overview of the results. Soc Psychiatry Psychiatr Epidemiol 1998;33:380386.
  • 29
    Rössler W, Joachim SH, Van OSJ, Riecher-Rössler A. Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol 2005;15:399409.
  • 30
    Amminger GP, Leicester S, Yung AR, Phillys LJ, Berger GE, Francey SM, Yuen HP, McGorry PD. Early onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals. Schizophr Res 2006; 84:6776.
  • 31
    Gschwandtner U, Aston J, Borgwardt S et al. Neuropsychological and neurophysiological findings in individuals suspected to be at risk for schizophrenia: preliminary results from the Basel early detection of psychosis study – Früherkennung von Psychosen (FEPSY). Acta Psychiatr Scand 2003;108:152155.
  • 32
    Gschwandtner U, Pfluger M, Aston J et al. Fine motor function and neuropsychological deficits in individuals at risk for schizophrenia. Eur Arch Psychiatry Clin Neurosci 2005;EPub ahead of print.
  • 33
    Borgwardt SJ, Radü EW, Götz K et al. Radiological findings in individuals at high risk of psychosis. J Neurol Neurosurg Psychiatry 2006;77:229233.
  • 34
    Gschwandtner U, Borgwardt S, Aston J, Drewe M, Radü EW, Riecher-Rössler A. [Chronic subdural hemorrhage in a patient with suspected schizophrenia prodrome]. Nervenarzt 2004;75:691693.